UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
Lexicon Genetics Incorporated
------------------------------------
(Name of Issuer)
Common
------------------------------------
(Title of Class of Securities)
528872 10 4
------------------------------------
(CUSIP Number)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[XX] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
CUSIP No. 528872 10 4 Page 2 of 6
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
BCM Technologies, Inc. 76-0112935
-------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
-------------------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
-------------------------------------------------------------------------------
NUMBER OF | 5. SOLE VOTING POWER
|
SHARES | 28,940
| -----------------------------------------------------------
BENEFICIALLY | 6. SHARED VOTING POWER
|
OWNED BY |
| -----------------------------------------------------------
EACH | 7. SOLE DISPOSITIVE POWER
|
REPORTING | [X]
| -----------------------------------------------------------
PERSON | 8. SHARED DISPOSITIVE POWER
|
WITH |
-------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
-------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
-------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
-------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
CO
-------------------------------------------------------------------------------
CUSIP No. 528872 10 4 Page 3 of 6
1. NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Baylor College of Medicine 74-1613878
-------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
-------------------------------------------------------------------------------
3. SEC USE ONLY
-------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Texas
-------------------------------------------------------------------------------
NUMBER OF | 5. SOLE VOTING POWER
|
SHARES | 4,036,060
| -----------------------------------------------------------
BENEFICIALLY | 6. SHARED VOTING POWER
|
OWNED BY |
| -----------------------------------------------------------
EACH | 7. SOLE DISPOSITIVE POWER
|
REPORTING | [X]
| -----------------------------------------------------------
PERSON | 8. SHARED DISPOSITIVE POWER
|
WITH |
-------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Baylor College of Medicine 4,007,120 *BCM Technologies 28,940
-------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
-------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
-------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
Internal Revenue Code 501 (c) (3) CO
-------------------------------------------------------------------------------
* BCM Technologies, Inc. is wholly owned by Baylor College of Medicine
Page 4 of 6
Item 1(a) Name of Issuer:
Lexicon Genetics Incorporated
-------------------------------------------------------------------------------
Item 1(b) Address of Issuer's Principal Executive Offices:
4000 Research Forest Drive
The Woodlands, TX 77381
-------------------------------------------------------------------------------
Item 2(a) Name of Person Filing:
Baylor College of Medicine & BCM Technologies, Inc.
-------------------------------------------------------------------------------
Item 2(b) Address of Principal Business Office:
One Baylor Plaza, T-100 MS BCM 203
Houston, TX 77030-3498
------------------------------------------------------------------------------
Item 2(c) Citizenship:
USA
-------------------------------------------------------------------------------
Item 2(d) Title of Class of Securities:
Common
-------------------------------------------------------------------------------
Item 2(e) CUSIP Number:
528872 10 4
-------------------------------------------------------------------------------
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or
13d-2(b), check whether the person filing is a:
(a)( ) Broker or Dealer registered under Section 15 of the Act
(b)( ) Bank as defined in Section 3(a)(6) of the Act
(c)( ) Insurance Company as defined in Section 3(a)(19) of the Act
(d)( ) Investment Company registered under Section 8 of the
Investment Company Act
(e)( ) Investment Adviser registered under Section 203 of the
Investment Advisers Act of 1940
(f)( ) Employee Benefit Plan, Pension Fund which is subject to
the provisions of the Employee Retirement Income Security
Act of 1974 or Endowment Fund; see (Section
240.13d-1(b)(1)(ii)(F)
(g)( ) Parent Holding Company, in accordance with Section
240.13d-1(b)(ii)(G)
(h)( ) Group, in accordance with Section 240.13d-1(b)(1)(ii)(H)
-------------------------------------------------------------------------------
Page 5 of 6
-------------------------------------------------------------------------------
Item 4 Ownership
If the percent of the class owned, as of December 31, of the year covered
by the statement, or as of the last day of any month described in Rule
13d-1(b)(2), if applicable, exceeds five percent, provide the following
information as of that date and identify those shares which there is a
right to acquire.
(a) Amount beneficially owned: Baylor College
4,036,060 of Medicine 4,007,120
BCM Technologies 28,940
(b) Percent of class:
6.3%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
[XX]
(ii) shared power to vote or to direct the
vote:
(iii) sole power to dispose or to direct the
disposition of:
(iv) shared power to dispose or to direct the
disposition of:
-------------------------------------------------------------------------------
Item 5 Ownership of Five Percent or Less of a Class:
If this statement is being filed to report the fact that as of the date
thereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following ( ).
-------------------------------------------------------------------------------
Item 6 Ownership of More than Five Percent on Behalf of Another
Person:
-------------------------------------------------------------------------------
Item 7 Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company:
-------------------------------------------------------------------------------
Item 8 Identification and Classification of Members of the Group:
-------------------------------------------------------------------------------
Item 9 Notice of Dissolution of Group:
-------------------------------------------------------------------------------
Item 10 Certification:
Page 6 of 6
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete, and
correct.
Dated: January 4, 2006 Baylor College of Medicine
--------------------------
By: /s/ WILLIAM D. WALKER
-----------------------
William D. Walker
Chief Investment Officer